Elaprase (idursulfase) for MPS II
Customize your policy alerts
Sign up for all CareSource policy alerts
Know when CareSource releases new policies or updates existing guidance.
Monitor payer policy activity
This policy governs medical prior authorization coverage for Elaprase (idursulfase), an enzyme replacement therapy for mucopolysaccharidosis type II (Hunter syndrome), for CareSource Arkansas PASSE members. It establishes diagnostic, prescriber, documentation, neurologic-status, dosing, and continuation requirements.
The policy history states that the age limit for Elaprase coverage was removed on December 29, 2023.
References were updated on May 5, 2026.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.